Form4insider filings, from the source

Company · CIK 0000883984 · SIC 3841 — Surgical & Medical Instruments & Apparatus · Nasdaq

ICU MEDICAL INC/DE · ICUI

Insider activity reported against this company. All insider holders · On EDGAR ↗

1M3M6M1Y2YAll datashares as filed — not split-adjusted
Open-market buys & salesbuys $0 · 0sales $6.6M · 7net −$6.6M
$10k$10k$100k$100k$1M$1M$10M$10MbuyssalesSep 2024Jan 2025May 2025Sep 2025Jan 2026May 2026Sep 2026

Reported at this company — common stock

TradeReported (ET)InsiderSharesAvg priceTotalOwned afterΔ stakeFlags
Sep 3, 2026 SForm 4 →Sep 3, 6:29 pm EDTVirginia Ruth SanzoneVP, General Counsel4,856$168.69$819,15014,604−25.0%10b5-1
Sep 1, 2026 SForm 4 →Sep 1, 5:21 pm EDTBrian Michael BonnellChief Financial Officer6,381$175.00$1,116,67556,062−10.2%10b5-1
Aug 31, 2026 SForm 4 →Aug 31, 4:43 pm EDTBrian Michael BonnellChief Financial Officer9,307$172.79$1,608,14362,443−13.0%10b5-1
Aug 13, 2026 SForm 4 →Aug 13, 6:56 pm EDTDaniel WoolsonVP, GM-Infusion Capital5,417$181.33$982,26517,062−24.1%
Aug 12, 2026 SForm 4 →Aug 12, 4:33 pm EDTBen SousaChief Information Officer2,250$178.32$401,2093,076−42.2%
Aug 11, 2026 SForm 4 →Aug 11, 6:18 pm EDTChristian B. VoigtlanderChief Operating Officer8,929$182.93$1,633,40437,377−19.3%
Aug 11, 2026 SForm 4 →Aug 11, 5:59 pm EDTElisha W FinneyDirector378$182.48$68,9784,871−7.20%

Reported at this company — derivatives (options, RSUs, warrants)

No reported derivative activity in this period.